SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
依小米
Lv6
2340 积分
2022-11-21 加入
最近求助
最近应助
互助留言
Phase Ib study of anlotinib in combination with anti-PD-L1ab(TQB2450) in patients with advanced acral melanoma
6个月前
已完结
What's the latest with investigational drugs for soft tissue sarcoma?
6个月前
已完结
The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
8个月前
已完结
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
8个月前
已完结
Efficacy and safety of anlotinib in patients with unresectable or metastatic well-differentiated/dedifferentiated liposarcoma: a single-center retrospective study
9个月前
已完结
A multicenter, randomized, double-blind, placebo-controlled phase III study of anlotinib or placebo in combination with gemcitabine and cisplatin (GP) as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC)
10个月前
已关闭
The efficacy of neoadjuvant chemotherapy as compared to upfront surgery for the management of oral squamous cell carcinoma: a systematic review and meta-analysis
11个月前
已完结
Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
1年前
已完结
How I use platelet transfusions
1年前
已完结
How I treat dysfibrinogenemia
1年前
已完结
没有进行任何应助
已经有人回复
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论